Please login to view this media
- Talk
- 20/09/2022
- UK
Outcomes of MAIA Dual Mobility CMC Joint Arthroplasty from a UK based Orthopaedic Hospital – With 3 years Follow-Up
Description
In this presentation, Srin Cheruvu discusses the early outcomes of the MAIA dual mobility arthroplasty, particularly focusing on trapeziometacarpal joint arthritis, which predominantly affects post-menopausal women. The presentation acknowledges Mr. Rushdie, the senior consultant, emphasizing the collaboration within the surgical team. A wide range of topics is covered, including patient decision-making regarding surgeries, non-operative treatments, and various operative techniques such as trapeziectomy, noting its variations and the gold standard status.
Cheruvu shares insights from their single center study which began in 2017, examining the outcomes of 52 patients who underwent this dual mobility prosthetic procedure. The median age of the patient population studied was 67, with the majority being female and showing significant left-side preponderance. The results indicate substantial pain relief and functional improvement post-surgery, with key metrics such as pain levels and Michigan hand outcome scores showing statistically significant enhancement.
Survivorship data presented shows an encouraging 96% from a four-year follow-up, with minimal complications linked to technical issues rather than the prosthesis design itself. The presentation highlights the promising low dislocation rates experienced with the dual mobility system compared to traditional methods. Cheruvu concludes by calling for more randomized controlled trials to broaden the understanding and establish further efficacy for such procedures in the face of established treatment standards.
Overall, the discussion sheds light on novel approaches in surgical management of hand conditions, underlining patient benefits, the significance of careful technique in implementation, and future research directions.